home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Female-Specific Genetic Risk Factor for Alzheimer's Disease

  January, 13 2009 18:05
your information resource in human molecular genetics

A variant in a gene on the X chromosome is associated with increased risk of Alzheimer's disease specifically in women, according to a study published online in Nature Genetics. This is the first evidence for a sex-specific genetic risk factor for this disease.

Late-onset Alzheimer's disease is a neurodegenerative disorder and is the most common cause of dementia in the elderly. Variation in the gene APOE is the only consistently replicated genetic risk factor known. Steven Younkin and colleagues carry out a genome-wide association study of individuals with Alzheimer's disease, and identify a variant in the gene PCDH11X as associated with susceptibility to the disease with a high degree of statistical significance. When the authors analyzed the data accounting for sex, they found that the association was almost entirely restricted to women. PCDH11X encodes a protein called a protocadherin, which is part of a family of molecules that promote cell-cell adhesion and signaling in the central nervous system. Some evidence suggests that protocadherins may be split to an active form by an enzyme linked to early-onset forms of Alzheimer's disease.

Author contact:

Steven Younkin (Mayo Clinic College of Medicine, Jacksonville, FL, USA)
E-mail: younkin.steven@mayo.edu

Abstract available online.

(C) Nature Genetics press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.